Premium
Evaluation of a Point‐of‐Care Influenza Antigen Test for the Detection of Highly Pathogenic Avian Influenza H5N1 Virus in Cats
Author(s) -
Marschall J.,
Schulz B.,
Hartmann K.
Publication year - 2008
Publication title -
transboundary and emerging diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.392
H-Index - 63
eISSN - 1865-1682
pISSN - 1865-1674
DOI - 10.1111/j.1865-1682.2008.01041.x
Subject(s) - cats , influenza a virus subtype h5n1 , virology , point of care testing , medicine , virus , influenza a virus , highly pathogenic , pandemic , point of care , diagnostic test , antigen , veterinary medicine , biology , immunology , covid-19 , pathology , disease , infectious disease (medical specialty)
Summary Quick diagnosis of H5N1 infection in cats is important because of the zoonotic and pandemic potential of this virus. Human rapid influenza antigen tests are also sold commercially to veterinarians for use in cats. The point‐of‐care test actim ™ Influenza A&B (Medix Biochemica, Kauniainen, Finland) was evaluated for the diagnosis of H5N1 infection in cats. The test showed a very low sensitivity and did not detect virus in samples of experimentally infected cats, so that its application cannot be recommended for the diagnosis of H5N1 infection in cats.